Companies / Inmune Bio, Inc.
Inmune Bio, Inc.
INMBCIK 1711754
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 10, 2021 | Xencor Inc 10% owner | Other Other (per filing) | Common Stock | $3.30M | +193K +12.15% | 1,777,533 | low |
| Jun 10, 2021 | Xencor Inc 10% owner | Other Other (per filing) | Common Stock | $3.30M | +193K +12.15% | 1,777,533 | low |
| Jun 10, 2021 | Xencor Inc 10% owner | Other Other (per filing) | Common Stock | $3.30M | +193K | — | low |
| Sep 3, 2021 | Xencor Inc 10% owner | Exercise Option exercise | Common Stock | $842.4K | +108K +6.08% | 1,885,533 | low |
| Jul 9, 2021 | Schroeder Timothy j Director | Sell Open-market sale | Common Stock | $696.1K | -30K -21.95% | 106,667 | medium |
| Jul 8, 2021 | Tesi Raymond Joseph CEO | Sell Open-market sale | Common Stock | $489.0K | -24K -1.59% | 1,510,933 | medium |
| Jul 8, 2021 | Lowdell Mark William Executive | Sell Open-market sale | Common Stock | $487.6K | -24K -1.61% | 1,476,251 | medium |
| Oct 22, 2021 | Tesi Raymond Joseph CEO | Sell Open-market sale | Common Stock | $472.3K | -24K -1.55% | 1,500,817 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| INMB | common | 45782T105 |